Rodent Models & Experiments for Optimizing the Preclinical Development of Obesity-Targeting Drugs

12:30 pm - Wednesday 15th July 2026

  • Delivering a brief yet comprehensive overview of diet-induced obesity (DIO) models and experiments used in drug efficacy studies
  • Discussing the pros and cons of DIO mouse, rat and hamster models used in the evaluation of obesity-targeting drugs
  • Providing reference and new data on GLP-1 and amylin therapies in these models

Speakers:

Director, Research & Business Development
Physiogenex